Marit J. van Gils

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten et al. · Science · 2020 · 1.3K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp, Dami A. Collier, Rawlings Datir et al. · Nature · 2021 · 1.1K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

Rogier W. Sanders, Ronald Derking, Albert Cupo et al. · PLoS Pathogens · 2013 · 1K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients

Daryl Geers, Marc C. Shamier, Susanne Bogers et al. · Science Immunology · 2021 · 593 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

HIV-1 neutralizing antibodies induced by native-like envelope trimers

Rogier W. Sanders, Marit J. van Gils, Ronald Derking et al. · Science · 2015 · 524 citations · Full text

Life Sciences, Immunology, Molecular Biology +17